| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | -100.0% |
| Cost of Revenue | $0 | — | — |
| R&D Expense | $19.9M | -27.0% | -6.5% |
| SG&A Expense | $16.2M | +3.4% | -9.3% |
| Operating Income | -$36.0M | +15.9% | +52.4% |
| Pre-tax Income | -$34.4M | +17.0% | +52.7% |
| Income Tax | $0 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $225.2M | +287.7% | +213.4% |
| Short-term Investments | $118.8M | -3.2% | -26.9% |
| Accounts Receivable | $132K | +28.2% | -92.4% |
| Current Assets | $353.4M | +89.1% | +44.1% |
| Total Assets | $362.7M | +86.4% | +44.7% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$95.4M | — | — |
| Capital Expenditures | $52K | — | — |
| Investing Cash Flow | -$15.4M | — | — |
| Financing Cash Flow | $257.2M | — | — |
| Free Cash Flow | -$95.5M | — | — |
| — |
| Net Income | -$34.4M | +17.0% | +52.7% |
| EPS (Basic) | -$0.37 | +19.6% | +65.4% |
| EPS (Diluted) | -$0.37 | +19.6% | +65.4% |
| $25.8M |
| +20.4% |
| -52.2% |
| Total Liabilities | $30.7M | +15.1% | -43.6% |
| Stockholders' Equity | $332.0M | +97.8% | +69.2% |